Over 1.3 billion population

Treatment naive patients across various indications

Largest pool of clinical trial naive patients

Genetic Diversity of the patients

Fast Recruitment & Maximum retention

Skilled medical & scientific community

Availability of western educated physicians

Enthusiastic professionals eager to take part in clinical studies

Most of the sites are trained in ICH GCP

Access to world class medical infrastructure

Progressive Regulatory Environment

Clinical trial registry in place in conformity with WHO Guidelines

English as a language for all business communications

Huge cost savings in clinical development phases of drugs